US FDA’s December User Fee Goals Look Hot-Blooded And Cancer-Free

 
• By Bridget Silverman
  
The FDA still could end the holiday season by matching its 2024 novel approval total. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers